SCHEMBL7262108

SCHEMBL7262108

CC(C)(C)c1cc(CO)ccc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.36
TTR P02766 2/20 0.34
S1PR1 P21453 4/20 0.34
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
MEN1 O00255 1/20 0.33
GMNN O75496 1/20 0.33
GABBR2 O75899 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7261819 0.86 DRD2 (0.40) DRD2PTGDR2ALDH1A1LMNATSHR
SCHEMBL3113521 0.84 DRD2 (0.41) DRD2TTRS1PR1NPC1POLB
SCHEMBL26491007 0.83 DRD2 (0.43) DRD2TTRS1PR1NPC1POLB
SCHEMBL6157222 0.82 DRD2 (0.35) DRD2S1PR1DHFR
SCHEMBL9128232 0.81 NPC1 (0.43) DRD2TTRNPC1POLBRAB9A
SCHEMBL499011 0.81 DRD2 (0.50) DRD2TTRS1PR1NPC1POLB
SCHEMBL3119147 0.81 DRD2 (0.56) DRD2TTRNPC1POLBRAB9A
SCHEMBL9959545 0.79 DRD2 (0.48) DRD2S1PR1NPC1POLBRAB9A
SCHEMBL10204755 0.78 CYP3A4 (0.47) TTRS1PR1NPC1POLBRAB9A
SCHEMBL9137815 0.78 DRD2 (0.40) DRD2TTRS1PR1NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0728018-B1 New enzymes and prodrugs for ADEPT WELLCOME FOUND (GB) 2003-08-06 EP disclosed
US-6319702-B1 NUCLEOTIDE SEQUENCS CODING AN ENZYMATIC POLYPEPTIDE AND CELL TARGETING COMPOUND; FOR USE IN TREATMENT OF CANCER GLAXO WELLCOME, INC. 2001-11-20 US disclosed
US-6140100-A CONJUGATE POLYPEPTIDE WHICH IS TISSUE PREFERENTIAL; ANTICARCINOGENIC AGENTS GLAXO WELLCOME INC. (US) 2000-10-31 US disclosed
EP-0728018-A1 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1996-08-28 EP disclosed
WO-1995013095-A2 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-18 WO disclosed